Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose Sinemet study of goal-directed and habitual behavior in schizophrenia
NL-OMON39093Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of levodopa in schizophrenia, sponsored by Erasmus MC. Primary endpoint: Cognitive functioning. Planned start Apr 2013; status: not yet recruiting.
02
Drugs
levodopa
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NL-OMON39093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39093.